Angle: Garth Selvey, Jan Groen
Angle has announced that its board chairman, Garth Selvey, plans to leave the company concurrent with the publication of the firm's 2023 interims in September, handing over the position to Jan Groen, currently an independent non-executive director on the board. Selvey initially became chairman in 2007, overseeing the clinical development of Angle's Parsortix cell-based liquid biopsy system, which received US Food and Drug Administration clearance for use in metastatic breast cancer last year.
Groen joined the Angle board in November 2018. He is currently CEO and chairman at Intravacc BV and was previously the CEO of MDxHealth and president and chief operating officer of Agendia.